Yi Xiao - Tongji Medical College, Huazhong University of Science and Technology

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 10 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Advances in Research on Factors Affecting Chimeric Antigen Receptor T-cell Efficacy

Delian Zhou,Xiaojian Zhu,Yi Xiao

Cancer medicine（2024）

引用0浏览0WOS引用

High-multiplex Single-Cell Imaging Analysis Reveals Tumor Immune Contexture Associated with Clinical Outcomes after CAR T-cell Therapy

Jin,Li Lin,Jiao Meng,Lijun Jiang, Man Zhang, Yuekun Fang,Wanying Liu,Xiangke Xin,Xiaolu Long,Dong Kuang, Xilai Ding,Miao Zheng,Yicheng Zhang,Yi Xiao,Liting Chen

MOLECULAR THERAPYno. 5 (2024): 1252-1265

引用0浏览0WOS引用

Efficacy of Programmed Cell Death 1 Inhibitor Maintenance after Chimeric Antigen Receptor T Cells in Patients with Relapsed/refractory B-cell Non-Hodgkin-lymphoma

Xiangke Xin,Xiaojian Zhu, Yang,Na Wang,Jue Wang,Jinhuan Xu,Jia Wei,Liang Huang,Miao Zheng,Yi Xiao,Chunrui Li,Yang Cao,Fankai Meng,Lijun Jiang,Yicheng Zhang

CELLULAR ONCOLOGYno. 4 (2024): 1425-1440

引用0浏览0WOS引用

Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients Following Treatment with Haploid Hematopoietic Stem Cell Transplantation Using Modified Post-transplantation Cyclophosphamide

Andie Fu,Yizhou Peng,Ping Cheng,Jiaying Wu,Xiaojian Zhu, Yang,Lifang Huang,Na Wang,Jue Wang,Jinhuan Xu,Yuling Wan,Yang Cao,Jia Wei,Yi Xiao,Fankai Meng,Hui Cheng,Yicheng Zhang,Donghua Zhang

TRANSPLANTATION AND CELLULAR THERAPYno. 5 (2024): 500-509

引用0浏览0WOS引用

Allogeneic CD19-targeted CAR-T Therapy in Patients with Severe Myositis and Systemic Sclerosis

Xiaobing Wang,Xin Wu,Binghe Tan,Liang Zhu,Yi Zhang,Li Lin,Yi Xiao, An Sun, Xinyi Wan,Shiyuan Liu,Yanfang Liu,Na Ta, Hang Zhang, Jialin Song,Ting Li,Ling Zhou,Jian Yin,Lingying Ye,Hongjuan Lu, Jinwei Hong, Hui Cheng, Ping Wang,Weiqing Li, Jianfeng Chen, Jin Zhang,Jing Luo, Miaozhen Huang, Lehang Guo, Xiaoming Pan, Yi Jin, Wenjing Ye,Lie Dai,Jian Zhu,Lingyun Sun, Biao Zheng,Dali Li,Yanran He,Mingyao Liu,Huaxiang Wu,Bing Du,Huji Xu

Cell（2024）

引用0浏览0WOS引用

Orelabrutinib Plus R-CHOP Regimen in Treatment-Naïve Patients with TP53-Mutated Diffuse Large B-Cell Lymphoma (DLBCL)

Yi Xiao,Jiaying Wu,Mi Zhou,Zhen Shang, Ming Zhu

BLOOD（2023）

引用0浏览0引用

Ksd-101 in Patients with EBV-Associated Hematologic Neoplasms: Results from an Ongoing Phase I Clinical Study

Chunrui Li,Di Wang, Atsuhiko Hasegawa, Huining Liu,Ning An,Yuhan Bao,Meijuan Huang,Yi Xiao,Donghua Zhang,Miao Zheng,Wei Huang,Lijun Jiang

Bloodno. Supplement 1 (2023): 4837-4837

引用0浏览0引用

Comparisons Between modified PTCY and G-CSF/ATG Regimens for Haploidentical Transplantation in Patients with Aplastic Anemia

Yun Li,Xuan Lu,Na Wang,Xiaoying Zhang,Yang Cao,Yi Xiao,Fankai Meng,Donghua Zhang,Yong You,Liang Zou,Hui Cheng,Jingming Guo,Youshan Zhang,Zhiping Huang,Guolin Yuan,Jia Wei,Huafang Wang,Linghui Xia,Yicheng Zhang

Biology of Blood and Marrow Transplantation (2022)

引用2浏览0引用

Clinical and genetic features of Epstein-Barr virus-triggered late-onset primary hemophagocytic lymphohistiocytosis: Ten pedigrees study

Lili Gao,Li Yang,Liang Huang,Yi Xiao,Jinniu Deng,Miao Zheng,Hui Luo,Lijun Jiang,Min Xiao,Chunrui Li,Jianfeng Zhou

CLINICAL AND TRANSLATIONAL MEDICINEno. 6 (2021): e393-e393

引用0浏览0WOS引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn